J. Findlay Walker

Statistics

Publications

Citations

676

H-Index

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

J. Findlay Walker is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and cardiovascular disease.

Top concepts

MedicinePharmacotherapyCardiovascular DiseasePharmacologyThrombosisAtherosclerosisCardiologyDrug SafetyBiochemistryHeart Failure

Publications per year

1983–2007

Publications

Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension

Richard B. Devereux, Vittorio Palmieri, Norman Sharpe et al. · Circulation · 2001 · 211 citations

Long-term safety and efficacy profile of simvastatin

Stephen J. Boccuzzi, Tomás S. Bocanegra, J. Findlay Walker et al. · The American Journal of Cardiology · 1991 · 114 citations

Drug Safety, Thrombosis, Cardiovascular Disease +5

Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension

Thomas D. Giles, Suzanne Oparil, T SILFANI et al. · Journal of Clinical Hypertension · 2007 · 81 citations · Full text

Simvastatin: The clinical profile

J. Findlay Walker · The American Journal of Medicine · 1989 · 78 citations

Thrombosis, Vascular Disease, Cardiovascular Disease +7

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol

Matti J. Tikkanen, Tomás S. Bocanegra, J. Findlay Walker et al. · The American Journal of Medicine · 1989 · 46 citations

Lipid Disorder, Low-dose Simvastatin, Cardiovascular Disease +6

1–5 of 13